Immunogenicity of meningococcal ACYW135 polysaccharide vaccine in Saudi children 5 to 9 years of age

Clinical and Diagnostic Laboratory Immunology

Volumn 12, Issue 10, 2005, Pages 1251-1253

  Khalil, M ^a   Al Mazrou, Y ^b   Balmer, P ^c   Bramwell, J ^c   Andrews, N ^d   Borrow, R ^c  

^a IMAM ABDULRAHMAN BIN FAISAL UNIVERSITY   (Saudi Arabia)

^b MINISTRY OF HEALTH   (Saudi Arabia)

^c MANCHESTER ROYAL INFIRMARY   (United Kingdom)

^d PUBLIC HEALTH ENGLAND   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBODY; IMMUNOGLOBULIN G; MENINGOCOCCUS VACCINE; POLYSACCHARIDE VACCINE;

ANTIBODY TITER; ARTICLE; CHILD; EPIDEMIC; FOLLOW UP; GROUPS BY AGE; HUMAN; IMMUNOGENICITY; MAJOR CLINICAL STUDY; MENINGOCOCCOSIS; PRIORITY JOURNAL; SAUDI ARABIA; SEROTYPE; STATISTICAL ANALYSIS; VACCINATION;

ANTIBODIES, BACTERIAL; CHILD; CHILD, PRESCHOOL; HUMANS; MENINGOCOCCAL VACCINES; SAUDI ARABIA; SEROTYPING; VACCINATION;

EID: 26944454380     PISSN: 1071412X     EISSN: None     Source Type: Journal    
DOI: 10.1128/CDLI.12.10.1251-1253.2005     Document Type: Article

References (14)

1. Al-Mazrou, Y., M. H. Al-Jeffri, M. N. Abadía, S. A. Elgizouli, and A. A. Mishskas. 2004. Changes in epidemiological pattern of meningococcal disease in Saudi Arabia. Does it constitute a new challenge for prevention and control? Saudi Med. J. 10:1410-1413.
2. Al-Mazrou, Y., M. Khalil, R. Borrow, P. Balmer, J. Bramwell, G. Lal, N. Andrews, and M. Al-Jeffri. 2005. Serologic responses to ACYW135 polysaccharide meningococcal vaccine in Saudi children under 5 years of age. Infect. Immun. 73:2932-2939.
3. Al-Mazrou, Y. Y., E. K. Musa, M. N. Abadía, M. H. Al-Jeffri, S. H. Al-Hajjar, and O. M. Mohammed. 2003. Disease burden and case management of bacterial meningitis among children under 5 years of age in Saudi Arabia. Saudi Med. J. 24:1300-1307.
4. Anonymous. 1992. Pilgrimage to Mecca (Hajj) 1992. Commun. Dis. Rep. CDR Wkly. 2(10):43.
5. Gold, R., M. L. Lepow, I. Goldschneider, T. L. Draper, and E. C. Gotschlich. 1975. Clinical evaluation of group A and group C meningococcal polysaccharide vaccines in infants. J. Clin. Investig. 56:1536-1547.
6. Guirguis, N., R. Schneerson, A. Bax, W. Egan, J. B. Robbins, J. Shiloach, I. Orskov, F. Orskov, and A. el Kholy. 1985. Escherichia coli K51 and K93 capsular polysaccharides are crossreative with the group A capsular polysaccharide of Neisseria meningitidis. Immunochemical, biological, and epidemiological studies. J. Exp. Med. 162:1837-1851.
7. Hajjeh, R. A., and J. Lingappa. 2000. Meningococcal disease in the Kingdom of Saudi Arabia: an evaluation of disease surveillance and control after an outbreak of serogroup W-135 meningococcal disease. CDC Rep. 23:2000.
8. Kayhty, H., V. Karanko, H. Peltola, S. Sarna, and P. H. Makela. 1980. Serum antibodies to capsular polysaccharide vaccine of group A Neissera [sic] meningitidis followed for three years in infants and children. J. Infect. Dis. 142:861-868.
9. Lal, G., P. Balmer, H. Joseph, M. Dawson, and R. Borrow. 2004. Development and evaluation of a multiplex flow cytometric assay for quantitation of serum antibodies to Neisseria meningitidis serogroups A, C, Y, and W135. Clin. Diagn. Lab. Immunol. 11:272-279.
10. Maiden, M. C., J. M. Stuart, and the UK Meningococcal Carriage Group. 2002. Carriage of serogroup C meningococci 1 year after meningococcal C conjugate polysaccharide vaccination. Lancet 349:1829-1831.
11. Maslanka, S. E., L. L. Gheesling, D. E. LiButti, K. B. J. Donaldson, H. S. Harakeh, J. K. Dykes, F. F. Arhin, S. J. Devi, C. E. Frasch, J. C. Huang, P. Kriz-Kuzemenska, R. D. Lemmon, M. Lorange, C. C. Peeters, S. Quataert, J. Y. Tai, and G. M. Carlone. 1997. Standardization and a multilaboratory comparison of Neisseria meningitidis serogroup A and C serum bactericidal assays. Clin. Diagn. Lab. Immunol. 4:156-167.
12. Peltola, H., H. Makela, H. Kayhty, H. Jousimies. E. Herva, K. Hallstrom, A. Sivonen, O. V. Renkonen, O. Pettay, V. Karanko, P. Ahvonen, and S. Sarna. 1977. Clinical efficacy of meningococcus group A capsular polysaccharide vaccine in children three months to five years of age. N. Engl. J. Med. 297:686-691.
13. Robbins, J. B., L. Myerowitz, J. K. Whisnant, M. Argaman, R. Schneerson, Z. T. Handzel, and E. C. Gotschlich. 1972. Enteric bacteria cross-reactive with Neisseria meningitidis groups A and C and Diplococcus pneumoniae types I and III. Infect. Immun. 6:651-656.
14. Vann, W. F., T. Y. Liu, and J. B. Robbins. 1976. Bacillus pumilus polysaccharide cross-reactive with meningococcal group A polysaccharide. Infect. Immun. 13:1654-1662.